Literature DB >> 2714937

Estrogens and the pathophysiology of Parkinson's disease.

R Sandyk1.   

Abstract

Two postmenopausal female Parkinsonian patients experienced exacerbation of symptoms including levodopa-induced "On-Off" following withdrawal or reduction of conjugated estrogen therapy. This report supports animal data implicating female sexual hormones in the pathophysiology of Parkinson's disease and levodopa-induced dyskinesias.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2714937     DOI： 10.3109/00207458908986223

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN： 0020-7454            Impact factor:   2.292


  15 in total

Review 1.  Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Authors:  Dean Dluzen; Martin Horstink
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 2.  Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?

Authors:  Rachel Saunders-Pullman
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 3.  Gender differences in neurological disease: role of estrogens and cytokines.

Authors:  Anna Członkowska; Agnieszka Ciesielska; Grazyna Gromadzka; Iwona Kurkowska-Jastrzebska
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 4.  Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Authors:  Elisabetta Vegeto; Valeria Benedusi; Adriana Maggi
Journal:  Front Neuroendocrinol       Date:  2008-04-29       Impact factor: 8.606

Review 5.  Effects of the Menstrual Cycle on Neurological Disorders.

Authors:  Hannah J Roeder; Enrique C Leira
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

6.  Perimenstrual Fluctuations in Two Siblings With Early-Onset Parkinson's Disease.

Authors:  Fabienne S Sprenger; Klaus Seppi; Elisabeth Wolf; Werner Poewe
Journal:  Mov Disord Clin Pract       Date:  2014-05-19

Review 7.  Sex-related differences in oxidative stress and neurodegeneration.

Authors:  Mavis A Tenkorang; Brina Snyder; Rebecca L Cunningham
Journal:  Steroids       Date:  2017-12-20       Impact factor: 2.668

Review 8.  Estrogen-BDNF interactions: implications for neurodegenerative diseases.

Authors:  Farida Sohrabji; Danielle K Lewis
Journal:  Front Neuroendocrinol       Date:  2006-10-27       Impact factor: 8.606

Review 9.  Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.

Authors:  Glenda E Gillies; Simon McArthur
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

10.  NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.

Authors:  Larissa Arning; Carsten Saft; Stefan Wieczorek; Jürgen Andrich; Peter H Kraus; Jörg T Epplen
Journal:  Hum Genet       Date:  2007-06-14       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.